[HTML][HTML] An update on the molecular and cellular basis of pharmacotherapy in type 2 diabetes mellitus

MO Mahgoub, II Ali, JO Adeghate, K Tekes… - International journal of …, 2023 - mdpi.com
Diabetes mellitus (DM) is a chronic illness with an increasing global prevalence. More than
537 million cases of diabetes were reported worldwide in 2021, and the number is steadily …

[HTML][HTML] Type-2 diabetes mellitus and the gut microbiota: Systematic review

E Slouha, A Rezazadah, K Farahbod, A Gerts… - Cureus, 2023 - ncbi.nlm.nih.gov
The gut microbiota is a community situated in the gastrointestinal tract that consists of
bacteria thriving and contributing to the functions of our body. It is heavily influenced by what …

[HTML][HTML] Promising influences of hesperidin and hesperetin against diabetes and its complications: a systematic review of molecular, cellular, and metabolic effects

A Mirzaei, A Mirzaei, SN Khalilabad, VR Askari… - EXCLI …, 2023 - ncbi.nlm.nih.gov
Hesperidin and hesperetin, two flavonoids with potential therapeutic value, have been
extensively studied in the context of diabetes management. The main objective of this …

[HTML][HTML] Treat Obesity to Treat Type 2 Diabetes Mellitus

C Sulu, VD Yumuk - Diabetes Therapy, 2024 - Springer
Obesity, a multifactorial, relapsing chronic disease, serves as a gateway to a spectrum of
metabolic, cardiovascular, mechanical and mental health problems. Over the last few …

[HTML][HTML] Recent Advances in Polysaccharides from Chaenomeles speciosa (Sweet) Nakai.: Extraction, Purification, Structural Characteristics, Health Benefits, and …

A Yu, W Hu, H Bi, L Fu, Z Wang, M Wang, H Kuang - Molecules, 2024 - mdpi.com
This article systematically reviews the extraction and purification methods, structural
characteristics, structure–activity relationship, and health benefits of C. speciosa …

[HTML][HTML] Oral Delivery of Liraglutide-Loaded Zein/Eudragit-Chitosan Nanoparticles Provides Pharmacokinetic and Glycemic Outcomes Comparable to Its …

J Ziebarth, LM da Silva, AKP Lorenzett, ID Figueiredo… - Pharmaceutics, 2024 - mdpi.com
Liraglutide (LIRA) is a glucagon-like peptide-1 (GLP-1) receptor agonist renowned for its
efficacy in treating type 2 diabetes mellitus (T2DM) and is typically administered via …

Associations Between Life's Essential 8 and Insulin Resistance Among Nondiabetic Adults

S Pang, Y Wang, S Sun, S Wang, F Li… - Journal of the …, 2023 - Am Heart Assoc
Background Insulin resistance (IR) is closely linked to cardiometabolic diseases. Preventing
and improving IR in nondiabetic populations is critically important. We aimed to investigate …

Diabetes Mellitus and Pneumococcal Pneumonia

C Cilloniz, A Torres - Diagnostics, 2024 - mdpi.com
Currently, there are more than 500 million people suffering from diabetes around the world.
People aged 65 years or older are the most affected by this disease, and it is estimated that …

[HTML][HTML] Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study

YF Yu, G Hu, KK Tong, XY Yang, JY Wu… - World Journal of …, 2024 - ncbi.nlm.nih.gov
AIM To analyze the causal correlation between different types of VH and T2D using
Mendelian randomization (MR). METHODS Single nucleotide polymorphisms of VH, chronic …

[HTML][HTML] Ge-Gen-Qin-Lian decoction alleviates the symptoms of type 2 diabetes mellitus with inflammatory bowel disease via regulating the AGE-RAGE pathway

Z Li, Z Zhao, S Chen, X Wang, D Wang, X Nie… - … Medicine and Therapies, 2024 - Springer
Background This study aimed to explore the mechanism of Ge-Gen-Qin-Lian decoction
(GGQLD) in the alleviation of symptoms of type 2 diabetes mellitus (T2DM) with inflammatory …